rs35761247
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_000094.4(COL7A1):c.3830C>T(p.Pro1277Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0518 in 1,613,924 control chromosomes in the GnomAD database, including 2,524 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P1277P) has been classified as Uncertain significance.
Frequency
Consequence
NM_000094.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COL7A1 | NM_000094.4 | c.3830C>T | p.Pro1277Leu | missense_variant, splice_region_variant | 31/119 | ENST00000681320.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COL7A1 | ENST00000681320.1 | c.3830C>T | p.Pro1277Leu | missense_variant, splice_region_variant | 31/119 | NM_000094.4 | P1 | ||
COL7A1 | ENST00000328333.12 | c.3830C>T | p.Pro1277Leu | missense_variant, splice_region_variant | 30/118 | 1 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0394 AC: 5999AN: 152092Hom.: 156 Cov.: 32
GnomAD3 exomes AF: 0.0431 AC: 10825AN: 251336Hom.: 318 AF XY: 0.0455 AC XY: 6178AN XY: 135854
GnomAD4 exome AF: 0.0531 AC: 77627AN: 1461714Hom.: 2367 Cov.: 34 AF XY: 0.0531 AC XY: 38636AN XY: 727156
GnomAD4 genome ? AF: 0.0394 AC: 5997AN: 152210Hom.: 157 Cov.: 32 AF XY: 0.0401 AC XY: 2985AN XY: 74406
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Epidermolysis bullosa dystrophica Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 22, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Recessive dystrophic epidermolysis bullosa Benign:1
Benign, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | May 31, 2018 | This variant is interpreted as a Benign - Stand Alone, for Epidermolysis bullosa dystrophica, autosomal recessive, in Autosomal Recessive manner. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at